U.S. states seek $26.4 billion from drug firms in opioid litigation: WSJ

[August 18, 2020]    (Reuters) - U.S. states are seeking a combined $26.4 billion from three major drug distributors and Johnson & Johnson <JNJ.N> to settle opioid litigation against the companies, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid/File Photo

About a dozen attorneys general are seeking a collective $21.14 billion from the distributors, which include McKesson Corp <MCK.N>, Amerisourcebergen <ABC.N> and Cardinal Health <CAH.N>, and $5.28 billion from J&J, the WSJ reported https://www.wsj.com/articles/states-seek-26-4-billion-from-drug-companies-in-opioid-litigation-11597743000?mod=searchresults&page=1&pos=2.

The companies did not immediately respond to Reuters' requests for comment.

The lawsuits accuse drugmakers of overstating the benefits of opioids while downplaying the risks and allege distributors failed to flag and halt a rising tide of suspicious orders.

A closely watched opioid trial pitting New York state against McKesson, Johnson & Johnson and others was postponed in March due to the coronavirus outbreak.

(Reporting by Manas Mishra in Bengaluru; Editing by Anil D'Silva)

[© 2020 Thomson Reuters. All rights reserved.]

Copyright 2020 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.